New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Abstract
a-1 adrenergic receptor antagonists prevent cytokine storm in mouse sepsis models. This led to the hypothesis that a-1 blockers might prevent severe Covid-19, which is characterized by hypercytokinemia and progressive respiratory failure.We performed an observational case-control study in male Medicare beneficiaries age =65 years, with or without benign prostatic hyperplasia (BPH), and treated with a-1 receptor blockers or 5-a reductase inhibitors. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were estimated for outcomes of uncomplicated and severe Covid-19 hospitalization (intensive care unit admission, invasive mechanical ventilation, or death).20,963 cases of hospitalized Covid-19 were matched to 101,161 controls on calendar date and neighborhood of residence. In the primary analysis (males with BPH), there was no difference in risk of uncomplicated Covid-19 hospitalization (aOR 1.08, 95% CI 0.996-1.17) or hospitalization with severe complications (aOR 0.97, 95% CI 0.88-1.08). In the secondary analysis (males with or without BPH), the corresponding aORs were 1.02, 95% CI 0.96-1.09 (uncomplicated), and 0.99, 95% CI 0.91-1.07 (complicated), respectively. Subgroup and sensitivity analyses yielded similar results. Of note, there was no difference in risk of severe Covid-19 hospitalization when comparing non-selective vs. selective a-1 blocker use (aOR 0.98, 95% CI 0.86-1.10), higher vs. lower dose a-1 blocker use (aOR 0.96, 95% CI 0.86-1.08), or current vs. remote a-1 blocker use (aOR 1.04, 95% CI 0.91-1.18).Prevalent use of a-1 receptor blockers was not associated with a protective or harmful effect on risk of uncomplicated or severe hospitalized Covid-19.
View details for DOI 10.1016/j.amjmed.2023.07.003
View details for PubMedID 37454868